Table 3 ROC and reclassification analysis evaluating the usefulness of IBI to improve the risk stratification of incident all-cause and cancer-specific mortality.
Outcomes | Model | AUC (95% CI) | P value | P for comparison | NRI (continuous) | P value | IDI | P value |
|---|---|---|---|---|---|---|---|---|
All-cause mortality | IBI | 0.708 (0.701–0.716) | < 0.001 | – | – | – | – | – |
Conventional risk factors* | 0.807 (0.802–0.812) | < 0.001 | – | – | – | – | – | |
Conventional risk factors + IBI | 0.808 (0.803–0.813) | < 0.001 | 0.012 | 0.200 (0.167–0.234) | < 0.001 | 0.003 (0.002–0.005) | < 0.001 | |
Cancer mortality | IBI | 0.632 (0.625–0.640) | < 0.001 | – | – | – | – | – |
Conventional risk factors* | 0.791 (0.785–0.798) | < 0.001 | – | – | – | – | – | |
Conventional risk factors + IBI | 0.799 (0.793–0.806) | < 0.001 | < 0.001 | 0.138 (0.103–0.279) | < 0.001 | 0.008 (0.005–0.010) | < 0.001 |